U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07269392) titled 'Dual Trigger With HCG and GnRH Agonist on Thawed Modified Natural Cycle Embryo Transfer' on Sept. 21.
Brief Summary: Impact of dual trigger using recombinant human chorionic gonadotropin (HCG) and gonadotropin-releasing hormone (GnRH) agonist on thawed modified natural cycle outcomes: an open-label multi-center randomized controlled trial.
Study Start Date: Jan. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Dual Trigger
Intervention:
DRUG: GnRH agonist
GnRH agonist add to hcg for trigger
Recruitment Status: NOT_YET_RECRUITING
Sponsor: National Taiwan University Hospital
Disclaimer: Curated by HT Syndication....